#SAVVEStudy - Twitter Hashtag

over 4 years ago

#ChronicVenousInsufficiency (CVI) is the country’s most prevalent #chronicdisease impacting ~175M U.S. adults. Enrolling now: The #SAVVEStudy, exploring our investigational product VenoValve® as a potential treatment for severe, deep venous #CVI. #VascTwitter #Vascular $NVNO

enVVenoMedical's tweet photo. #ChronicVenousInsufficiency (CVI) is the country’s most prevalent #chronicdisease impacting ~175M U.S. adults.

Enrolling now: The #SAVVEStudy, exploring our investigational product VenoValve® as a potential treatment for severe, deep venous #CVI. #VascTwitter #Vascular $NVNO

0

1

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

Patients with #ChronicVenousInsufficiency (CVI) have limited options to manage this debilitating disease. The #SAVVEStudy is examining our investigational product, the VenoValve®, as a potential treatment for severe, deep venous #CVI. #CardioTwitter #VenousDisease #Vascular

enVVenoMedical's tweet photo. Patients with #ChronicVenousInsufficiency (CVI) have limited options to manage this debilitating disease.

The #SAVVEStudy is examining our investigational product, the VenoValve®, as a potential treatment for severe, deep venous #CVI. #CardioTwitter #VenousDisease #Vascular

0

6

2

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

Patients living with CVI experience debilitating symptoms: - leg swelling - discoloration, itchiness & pain - difficult-to-heal sores They may be eligible for the #SAVVEStudy for our investigational product VenoValve®. Learn about the #clinicaltrial. #VascTwitter #VenousCare

0

2

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

- Executed on US pivotal #SAVVEStudy evaluating the VenoValve®, as a potential treatment for CVI - Bolstered cash position with $20M registered direct offering with leading life sciences investment firm $NVNO #VascTwitter #CardioTwitter #VenousNews #MedTechNews

enVVenoMedical's tweet photo. - Executed on US pivotal #SAVVEStudy evaluating the
VenoValve®, as a potential treatment for CVI
- Bolstered cash position with $20M registered direct offering with leading life sciences investment firm $NVNO #VascTwitter #CardioTwitter #VenousNews #MedTechNews

0

2

1

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

Having #CVI is like trying to climb a ladder with a broken rung & gravity weighing you down; valves in the legs malfunction & blood pools in the limbs vs. moving up to the heart. The #SAVVEStudy is studying a potential option for this #VenousDisease. #CardioTwitter #VascTwitter

0

7

3

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

Patients living with CVI experience debilitating symptoms: 🦵🏾leg swelling 🟪discoloration 😖itchiness 💥pain 🩹difficult to heal sores They may be eligible for the #SAVVEStudy for our investigational product VenoValve®. Learn about the #clinicaltrial. #VascTwitter #VenousCare

0

3

2

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

Congrats @AlbanyMed on this milestone for the #SAVVEStudy! With no effective treatments, CVI has been frustrating the vascular community & patients for decades. Learn about the pivotal U.S. #ClinicalTrial & how to enroll @ https://t.co/KEzYhGVvtq $NVNO #VascTwitter #CardioTwitter

enVVenoMedical's tweet photo. Congrats @AlbanyMed on this milestone for the #SAVVEStudy! With no effective treatments, CVI has been frustrating the vascular community & patients for decades. Learn about the pivotal U.S. #ClinicalTrial & how to enroll @ https://t.co/KEzYhGVvtq $NVNO #VascTwitter #CardioTwitter

0

2

1

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

A milestone for the pivotal #SAVVEStudy, congrats to @AlbanyMed for treating the 1st U.S. patient with VenoValve®!💜 The #clinicaltrial is enrolling, find out about the study investigating the VenoValve for the potential treatment of CVI. $NVNO #VascTwitter #CardioTwitter

enVVenoMedical's tweet photo. A milestone for the pivotal #SAVVEStudy, congrats to @AlbanyMed for treating the 1st U.S. patient with VenoValve®!💜

The #clinicaltrial is enrolling, find out about the study investigating the VenoValve for the potential treatment of CVI. $NVNO #VascTwitter #CardioTwitter

0

6

4

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

Patients with #ChronicVenousInsufficiency (CVI) have limited options to manage this debilitating disease. The #SAVVEStudy is examining our investigational product, the VenoValve®, as a potential treatment for severe, deep venous #CVI. #VascTwitter #VenousDisease #Vascular

0

5

2

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

#ChronicVenousInsufficiency (CVI) is the country’s most prevalent #chronicdisease impacting ~175M U.S. adults. Enrolling now: The #SAVVEStudy, exploring our investigational product VenoValve® as a potential treatment for severe, deep venous #CVI. #VascTwitter #Vascular $NVNO

0

6

3

0

enVVeno Medical

@enVVenoMedical

over 4 years ago

We're excited to welcome @AlbanyMed as a site in our #SAVVEStudy! 💜 Currently enrolling, the #clinicaltrial is studying our investigational device, the VenoValve®, as a potential treatment for #ChronicVenousInsufficiency. #VenousDisease #VenousNews #VascTwitter $NVNO

enVVenoMedical's tweet photo. We're excited to welcome @AlbanyMed as a site in our #SAVVEStudy! 💜

Currently enrolling, the #clinicaltrial is studying our investigational device, the VenoValve®, as a potential treatment for #ChronicVenousInsufficiency.

#VenousDisease #VenousNews #VascTwitter $NVNO

0

3

1

0

Top Tweets for #SAVVEStudy

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users